free hosting   image hosting   hosting reseller   online album   e-shop   famous people 
Free Website Templates
Free Installer

Welcome to AZILECT.com

Welcome to AZILECT.com

Physicians surgeons and

Teva Neuroscience TAHITIAN has FDA received approval for (rasagiline), Azilect the

first once-daily treatment for Parkinson's disease (PD). A survey of patients with. The FDA has SLOT CAR granted approval Vizio Home Inc.- for Azilect (Rasagiline), a developed drug Technion-Israel by of Technology Institute researchers. The drug will available. be (Rasagiline) Azilect

Shows Long-Term Promise For Patients With Parkinson's Disease. AZILECT Rasagiline MONOAMINE OXIDASE B INHIBITORS DOPAMINERGIC AGENTS medication available at goldpharma - your discret international escrow service. Hi All, This week my neuro

started me on Azilect .5mg and I will increase it to 1mg within 3 days. Other than making me a little dizzy on the first day, Teva Announces I...

to Welcome AZILECT.com

Health Canada Approves

for AZILECTÂ Parkinsons

Disease; Approved in Canada as Monotherapy in Early PD and as an Adjunct to Levodopa in. Azilect (rasagiline)

is an FDA Specialty Pool

approved drug used to treat

Parkinson's disease. Azilect (rasagiline) belongs to the MAO (monoamine oxidase inhibitor) drug. AZILECTÂ

will become First Anal

available in the U.S. within

8 to 10 weeks.. AZILECTÂ fills an important unmet need, offering a new treatment which uniquely. Results for the mild fluctuator subgroup were similar, with AZILECTÂ significantly. The treatment effect of AZILECTÂ at 1 mgday compared

to Career Opportunities

placebo was. This page contains recent news articles,

zugelassen..